How much funding has CiBiEM raised?

CiBiEM has raised $10.0M in total funding, most recently a Series A round.

Who are CiBiEM's investors?

CiBiEM's investors include SV Life Sciences, Third Rock Ventures.

Where is CiBiEM headquartered?

CiBiEM is headquartered in Los Altos, California, United States.

CiBiEM

Closed

Los Altos, United States · Founded 2010 · $10.0M raised

Healthcare

Headquarters: Los Altos, California
Founded: 2010
Business Model: B2B
Website: cibiem.com

Total Funding: $10.0M
Last Round: $10.0M Series AOct 2012
Rounds: 1

About

CiBiEM (formerly CIBIEM, Inc.) was a medical device company that developed minimally invasive, catheter-based transvenous therapies targeting Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases, including hypertension, heart failure, diabetes, and renal failure. The company was co-founded by Mark Gelfand and Howard R. Levin, M.D. — the team behind Coridea — and developed a novel patient pre-screening method to identify individuals likely to respond to CBM therapy. CIBIEM was backed by Third Rock Ventures, SV Health Investors, and BioStar Ventures, and filed 13 patents before ceasing operations.

Summary

CiBiEM is a Healthcare company based in Los Altos, United States, founded in 2010. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Oct 2012. Investors include SV Life Sciences and Third Rock Ventures.